Ftse Mib
33.629,21
-0,32%
DAX
18.001,60
0,54%
S&P 500
5.127,79
1,26%
NASDAQ
16.156,33
1,99%
Bitcoin
64.065,96
1,87%

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ Relmada Therapeutics Inc (RLMD) Relmada Therapeutics Inc (RLMD) Notizie

Relmada Therapeutics Inc

RLMD
3,68
-0,04 (-1,08%)
03 Mag 2024 - Chiuso
Dati in Delay di 15 minuti
Borsa: NASDAQ
Tipo: Azione
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
19/3/202412:27IHMARKETNEWSUS Index Futures Decline Ahead of Federal Reserve Meeting,..
20/2/202423:55EDGAR2Form 144 - Report of proposed sale of securities
14/2/202414:53EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
01/2/202400:29EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01/2/202400:28EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01/2/202400:28EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11/1/202422:30EDGAR2Form 8-K - Current report
04/1/202414:11EDGAR2Form 8-K - Current report
03/1/202423:00EDGAR2Form 8-K - Current report
19/12/202323:28EDGAR2Form 4 - Statement of changes in beneficial ownership of..
19/12/202323:28EDGAR2Form 4 - Statement of changes in beneficial ownership of..
19/12/202323:28EDGAR2Form 4 - Statement of changes in beneficial ownership of..
19/12/202323:27EDGAR2Form 4 - Statement of changes in beneficial ownership of..
19/12/202323:27EDGAR2Form 4 - Statement of changes in beneficial ownership of..
19/12/202323:27EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/11/202322:05EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
08/11/202322:01EDGAR2Form 8-K - Current report
11/10/202315:00EDGAR2Form 8-K - Current report
10/10/202323:18EDGAR2Form 8-K - Current report
04/10/202314:53EDGAR2Form 8-K - Current report
20/9/202322:47EDGAR2Form 8-K - Current report
06/9/202315:23EDGAR2Form 8-K - Current report
10/8/202322:54EDGAR2Form 8-K - Current report
08/8/202322:29EDGAR2Form 8-K - Current report
08/8/202322:01EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
12/5/202311:45PRNUSRLMD FRAUD ALERT: Jakubowitz Law is Investigating Relmada..
10/5/202311:45PRNUSINVESTIGATION ALERT: The Gross Law Firm Notifies..
05/5/202311:45PRNUSRLMD FRAUD ALERT: Jakubowitz Law is Investigating Relmada..
Apertura: 3,80 Min: 3,63 Max: 3,93
Chiusura: 3,72

La tua Cronologia

NASDAQ
RLMD
Relmada Therapeutics
Delayed Upgrade Clock

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' CLICCA QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network